Evaluation of Vaccine Supply Chain Performance Activities of Health Systems in the COVID 19 Pandemic Period with DEA: European Countries

Basit Öğe Kaydı
dc.authorscopusid58244824700
dc.authorscopusid58103322600
dc.contributor.authorBayrak Ö.A.
dc.contributor.authorGöncü K.K.
dc.date.accessioned2024-06-12T10:24:50Z
dc.date.available2024-06-12T10:24:50Z
dc.date.issued2023
dc.description.abstractIn this paper, the linkage of two different concepts; sustainable competitive advantage (SCA) and Supply Management (SM) are analyzed. SCA has been gaining attention in last decades. Companies have been trying to obtain SCA in order to be successful and keep their position in the future. As competition intensifies among enterprises, each enterprise seeks to research how to reduce costs and/or achieve excellence compared to competitors in the market. One of the areas that the enterprise can exploit to achieve a sustainable competitive advantage is the supply chain. Supply chain management (SCM) philosophy is based on collaboration of suppliers, manufacturers and distributers. SM is a vital part of SCM and SM has been gaining importance in the last decades according to several factors. Sustainable SM activities may provide supply chain SCA from many aspects. It is argued that Supply Management (SM) is linked with performance and effects on SCA directly or indirectly. In this chapter, the health systems vaccine supply chain performance activities were evaluated with DEA during the COVID 19 pandemic period, using the health indicators of European countries for January 2022 in Trading Economics and WHO databases. © 2023, The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.en_US
dc.identifier.doi10.1007/978-981-19-9079-3_12
dc.identifier.endpage246en_US
dc.identifier.issn2509-7873
dc.identifier.scopus2-s2.0-85159121167en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage225en_US
dc.identifier.urihttps://doi.org/10.1007/978-981-19-9079-3_12
dc.identifier.urihttps://hdl.handle.net/20.500.14551/16053
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherSpringer Natureen_US
dc.relation.ispartofAccounting, Finance, Sustainability, Governance and Frauden_US
dc.relation.publicationcategoryKitap Bölümü - Uluslararasıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCovid-19; Dea; European Countries; Supply Chain Performanceen_US
dc.titleEvaluation of Vaccine Supply Chain Performance Activities of Health Systems in the COVID 19 Pandemic Period with DEA: European Countriesen_US
dc.typeBook Chapteren_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu